Fact CheckerSign in

NCT07630883Not yet recruiting

A Pilot Study: Micro and NanoPlastics in Association With Crohn's Disease

Integrated Multi-phase Investigation of Role of Micro and NanoPlastics in Association With Crohn's Disease: Targeting Microbiome, Immunity, and Barrier Dysfunction: A Pilot Study

Source: ClinicalTrials.gov · Last updated 5 Jun 2026

Brief summary (registry, in English)

Micro and nanoplastics (MNPs) are environmental contaminants found in food and water. Recent evidence suggests these particles may be linked to intestinal inflammation and changes in gut bacteria, which are key features of Crohn's Disease (CD). This study aims to investigate if patients with Crohn's Disease have a reduced ability to clear these plastic particles and how this affects their immune system and intestinal health.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
90 (estimated)
First submitted
2 Jun 2026
Start date
15 Jun 2026
Primary completion date
30 Jun 2031
Lead sponsor
Mak Wing Yan
NCT number
NCT07630883

What you commit to

  • Study type: Observational
  • Planned participants: 90
  • From 15 Jun 2026 to the primary completion date, 30 Jun 2031
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of gastrointestinal malignancy
  • Advanced terminal medical illness, e.g. terminal malignancies; end staged renal failure and liver failure
    • Control:
  • Advanced terminal medical illness, e.g. terminal malignancies; end staged renal failure and liver failure

Other

  • Cases:
  • Antibiotic/probiotic use within 4 weeks
  • Presence of stoma
  • Currently Pregnant
  • Currently Pregnant
  • Inability in giving consent

Who the study is looking for

  • Cases:
  • Age 18-80 years
  • Confirmed diagnosis of Crohn's disease (for cases)
  • Ability to provide informed consent.
    • Control:
  • Age 18-80 years old
  • No history of major large bowel resection
  • Ability to provide informed consent.

Age in the registry: 18 years to 80 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prince of Wales Hospital
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.